https://orcid.org/0000-0003-2276-1524
Graphical Abstract
Categories of hypertriglyceridaemia, associated triglyceride-rich lipoproteins, corresponding risk of major adverse cardiovascular events, and implications for triglyceride-lowering cardiovascular outcome trials. ANGPTL3, angiopoietin-like protein 3; ApoC3: apolipoprotein C-III; CE, cholesteryl ester; CM, chylomicron; CVOT, cardiovascular outcome trials; FCS, familial chylomicronemia syndrome; HTG, hypertriglyceridaemia; IDL, intermediate-density lipoprotein; MACE, major adverse cardiovascular events; MCS, multifactorial chylomicronemia syndrome; TG, triglyceride; VLDL, very-low-density lipoprotein.
© The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact [email protected] for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact [email protected].
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/pages/standard-publication-reuse-rights)
